Comparison between coagulation factor VIII quantified with one‐stage activity assay and with mass spectrometry in haemophilia A patients: Proof of principle-Reference-Cited by-同舟云学术

Comparison between coagulation factor VIII quantified with one‐stage activity assay and with mass spectrometry in haemophilia A patients: Proof of principle

Published:2020-07-06 Issue:6 Volume:42 Page:819-826
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int J Lab Hem

Author:

Donners Anouk A. M. T.¹^ORCID,Maarseveen Erik M.¹,Weetink Yrea R. J.¹,El Amrani Mohsin¹²,Fischer Kathelijn³,Rademaker Carin M. A.¹,Egberts Toine C. G.¹⁴,Huisman Albert²^ORCID,Musson Ruben E. A.²

Affiliation:

1. Department of Clinical Pharmacy University Medical Centre Utrecht Utrecht The Netherlands

2. Clinical Chemistry and Haematology University Medical Centre Utrecht Utrecht The Netherlands

3. Van Creveldkliniek University Medical Centre Utrecht Utrecht The Netherlands

4. Division of Pharmacoepidemiology and Clinical Pharmacology Department of Pharmaceutical Sciences Faculty of Science Utrecht University The Netherlands

Publisher

Wiley

Subject

Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijlh.13283

Reference25 articles.

1. A study of reported factor VIII use around the world

2. Haemophilias A and B

3. Past, present and future of hemophilia: a narrative review

4. Definitions in hemophilia: communication from the SSC of the ISTH

5. Mild Hemophilia in Children

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of emicizumab by mass spectrometry in plasma of people with hemophilia A: A method validation study;Research and Practice in Thrombosis and Haemostasis;2022-04